Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
URGN
#2067
UroGen Pharma Ltd. Ordinary Shares
21.700
0
+4.28%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+4.28%
Monthly Change
-0.60%
6 month change
+14.21%
Year Change
+14.21%
Previous Close
20.810
0
Open
21.700
0
Bid
Ask
Low
21.700
0
High
21.700
0
Volume
74
Markets
US Stock Market
Healthcare
URGN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
UroGen Pharma CMO Schoenberg sells $145k in shares
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
2025 Performance Review And Future Strategy
Urogen Pharma Ltd stock hits 52-week high at 25.2 USD
UroGen Pharma at Guggenheim Conference: Strategic Insights into UGN-102 Launch
Urogen Pharma stock hits 52-week high at 23.66 USD
UroGen Pharma Ltd. (URGN) Q3 2025 Earnings Call Transcript
UroGen Pharma stock jumps after positive Phase 3 trial results
UroGen Pharma stock price target raised to $30 from $25 at D. Boral Capital
Urogen Pharma (URGN) Reports Q3 Loss, Misses Revenue Estimates
UroGen Pharma earnings missed, revenue fell short of estimates
UroGen reports 77.8% response rate in bladder cancer drug trial